Related Experiment Video
Updated: May 14, 2026
07:18
Lipid Bilayer Experiments with Contact Bubble Bilayers for Patch-Clampers
Published on: January 16, 2019
Structural determinants of specific lipid binding to potassium channels
Markus Weingarth1, Alexander Prokofyev, Elwin A W van der Cruijsen
1Bijvoet Center for Biomolecular Research, Faculty of Science, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.
Journal of the American Chemical Society
|February 22, 2013
Summary
Specific lipid binding regulates KcsA potassium channel activity near the selectivity filter. A mutation in KcsA-Kv1.3 channels reduces this lipid interaction, impacting channel function and protein-protein interactions.
Area of Science:
- Membrane biophysics
- Structural biology
- Molecular dynamics simulations
Background:
- Potassium channels are crucial for cellular function.
- Lipid interactions with ion channels are vital but not fully understood.
- KcsA and Kv1.3 channels represent distinct classes of potassium channels.
Purpose of the Study:
- To investigate lipid binding to KcsA and KcsA-Kv1.3 channel pore domains.
- To elucidate the structural and functional impact of specific lipid-protein interactions.
- To understand how mutations affect lipid binding and channel activity.
Main Methods:
- Coarse-grained and atomistic molecular dynamics simulations.
- Solid-state Nuclear Magnetic Resonance (NMR) spectroscopy.
- Single channel electrophysiological measurements.
Main Results:
- Anionic nonannular lipids specifically bind to KcsA near the selectivity filter, modulating its activity.
- Lipid binding's influence on the chimeric KcsA-Kv1.3 channel is significantly reduced.
- A mutation in KcsA-Kv1.3 creates a salt bridge, hindering strong nonannular lipid binding.
Conclusions:
- Protein-lipid and protein-protein interactions critically modulate K(+) channel activity.
- The study highlights the role of specific lipid-protein interactions in channel regulation.
- Combined simulation and experimental approaches are effective for studying membrane protein dynamics.
Related Concept Videos
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:18The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:21Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles in drug...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles in drug...